SREBF1 and metabolic dysfunction-associated steatotic liver disease: Collectively, E. coli NF73-1-mediated disruption of mTOR-S6K1-SREBP-1/PPAR-α signaling caused the disruption of triglyceride synthesis and oxidation in NAFLD mice.